Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Common side effects of Tucatinib and management suggestionsLike other medications, Tucatinib may cause side effects, but not everyone will experience them. Very common side effects···【more】
Article source：Captain MedicineRelease date：2026-05-26Recommended：103
Standard Dose and Administration of TucatinibThe recommended dose of tucatinib is 300 mg taken orally twice daily. As the tablets are available in 150 mg strength, this corresponds···【more】
Article source：Captain MedicineRelease date：2026-05-26Recommended：103
In which cases is it absolutely contraindicated or necessary to use Tucatinib with caution?First, if you are allergic to tucatinib or any other ingredients in tucatinib tablets (su···【more】
Article source：Captain MedicineRelease date：2026-05-26Recommended：83
What kind of drug is Tucatinib?Tucatinib is a prescription medicine used to treat breast cancer, with the active ingredient being tucatinib. It belongs to a class of drugs called &···【more】
Article source：Captain MedicineRelease date：2026-05-26Recommended：87
Correct Administration of TucatinibTucatinib is an oral tablet taken twice daily, within 30 minutes after a meal. It is used in combination with trastuzumab (usually administered i···【more】
Article source：Captain MedicineRelease date：2026-05-25Recommended：91
Common Side Effects of Tucatinib and Their ManagementIn clinical studies, nearly all patients experienced some side effects, but most were mild to moderate. When tucatinib is combi···【more】
Article source：Captain MedicineRelease date：2026-05-25Recommended：113
Is Tucatinib Effective for Treatment?The efficacy and safety of tucatinib are based on a clinical study called HER2CLIMB. This study enrolled 612 adult patients with HER2-positive ···【more】
Article source：Captain MedicineRelease date：2026-05-25Recommended：110
What is Tucatinib?Tucatinib is an oral targeted therapy drug that must be used in combination with Herceptin® (trastuzumab) and Xeloda® (capecitabine). It is indicated for adult pa···【more】
Article source：Captain MedicineRelease date：2026-05-25Recommended：109
Brigatinib: Serious and Common Side EffectsBrigatinib may cause a variety of side effects, not everyone experiences them. If the following serious reactions occur, tell your doctor···【more】
Article source：Captain MedicineRelease date：2026-05-22Recommended：110
Standard Dosage and Initial Treatment Regimen of BrigatinibBrigatinib must be taken exactly as directed by your doctor or pharmacist. The recommended dosage is given in two phases:···【more】
Article source：Captain MedicineRelease date：2026-05-22Recommended：87
Indications and Mechanism of Action of BrigatinibBrigatinib is used to treat adult patients with advanced non-small cell lung cancer, especially those whose tumors have a genetic d···【more】
Article source：Captain MedicineRelease date：2026-05-22Recommended：88
Health conditions you must tell your doctor about before using brigatinibBefore starting treatment with Alunbrig (brigatinib) and during treatment, you must contact your doctor imm···【more】
Article source：Captain MedicineRelease date：2026-05-22Recommended：81
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：4692025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：6492024-09-07
On May 28, 2026, AstraZeneca announced that its immunotherapy drug Imfinzi (durvalumab) in combinati···【more】
Recommended：1082026-01-06
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended：4312025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended：4532025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended：4362025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：4942025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：4002025-01-12
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
